Skip to Main Content
Gareth J. Morgan

Gareth J. Morgan

Perlmutter Cancer Center

Professor, Department of Medicine

Positions

Professor, Department of Medicine

Director, Multiple Myeloma Research Perlmutter Cancer Center

Phone

212-263-0649

Is this your profile?
Edit profile
Academic office

550 First Avenue, Smilow Building

10th Floor, 1001C

NYC, NY 10016

Response-adapted intensification with cyclophosphamide, bortezomib, and dexamethasone versus no intensification in patients with newly diagnosed multiple myeloma (Myeloma XI): a multicentre, open-label, randomised, phase 3 trial

Jackson, Graham H; Davies, Faith E; Pawlyn, Charlotte; Cairns, David A; Striha, Alina; Collett, Corinne; Waterhouse, Anna; Jones, John R; Kishore, Bhuvan; Garg, Mamta; Williams, Cathy D; Karunanithi, Kamaraj; Lindsay, Jindriska; Wilson, Jamie N; Jenner, Matthew W; Cook, Gordon; Kaiser, Martin F; Drayson, Mark T; Owen, Roger G; Russell, Nigel H; Gregory, Walter M; Morgan, Gareth J

Lancet. Haematology. 2019 Dec; 6(12):e616-e629

The relative importance of factors predicting outcome for myeloma patients at different ages: results from 3894 patients in the Myeloma XI trial

Pawlyn, Charlotte; Cairns, David; Kaiser, Martin; Striha, Alina; Jones, John; Shah, Vallari; Jenner, Matthew; Drayson, Mark; Owen, Roger; Gregory, Walter; Cook, Gordon; Morgan, Gareth; Jackson, Graham; Davies, Faith

Leukemia. 2019 Oct 14;

Clonal evolution in myeloma: the impact of maintenance lenalidomide and depth of response on the genetics and sub-clonal structure of relapsed disease in uniformly treated newly diagnosed patients

Jones, John R; Weinhold, Niels; Ashby, Cody; Walker, Brian A; Wardell, Christopher; Pawlyn, Charlotte; Rasche, Leo; Melchor, Lorenzo; Cairns, David A; Gregory, Walter M; Johnson, David; Begum, Dil B; Ellis, Sidra; Sherborne, Amy L; Cook, Gordon; Kaiser, Martin F; Drayson, Mark T; Owen, Roger G; Jackson, Graham H; Davies, Faith E; Greaves, Mel; Morgan, Gareth J

Haematologica (Roma). 2019 Jul; 104(7):1440-1450

Combination of flow cytometry and functional imaging for monitoring of residual disease in myeloma

Rasche, L; Alapat, D; Kumar, M; Gershner, G; McDonald, J; Wardell, C P; Samant, R; Van Hemert, R; Epstein, J; Williams, A F; Thanendrarajan, S; Schinke, C; Bauer, M; Ashby, C; Tytarenko, R G; van Rhee, F; Walker, B A; Zangari, M; Barlogie, B; Davies, F E; Morgan, G J; Weinhold, N

Leukemia. 2019 Jul; 33(7):1713-1722

FRAX is a robust predictor of baseline vertebral fractures in multiple myeloma patients

Atrash, Shebli; Dua, Isha; Buros, Amy F; Van Rhee, Fritz; Suva, Larry J; Thanendrarajan, Sharmilan; Schinke, Carolina; Davies, Faith; Morgan, Gareth; Zangari, Maurizio

Bone. 2019 Apr; 121:134-138

A clinical prediction model for outcome and therapy delivery in transplant-ineligible patients with myeloma (UK Myeloma Research Alliance Risk Profile): a development and validation study

Cook, Gordon; Royle, Kara-Louise; Pawlyn, Charlotte; Hockaday, Anna; Shah, Vallari; Kaiser, Martin F; Brown, Sarah R; Gregory, Walter M; Child, J Anthony; Davies, Faith E; Morgan, Gareth J; Cairns, David A; Jackson, Graham H

Lancet. Haematology. 2019 Mar; 6(3):e154-e166

Subclonal evolution in disease progression from MGUS/SMM to multiple myeloma is characterised by clonal stability

Dutta, Ankit K; Fink, J Lynn; Grady, John P; Morgan, Gareth J; Mullighan, Charles G; To, Luen B; Hewett, Duncan R; Zannettino, Andrew C W

Leukemia. 2019 Feb; 33(2):457-468

Mesenchymal stem cells gene signature in high-risk myeloma bone marrow linked to suppression of distinct IGFBP2-expressing small adipocytes

Mehdi, Syed J; Johnson, Sarah K; Epstein, Joshua; Zangari, Maurizio; Qu, Pingping; Hoering, Antje; van Rhee, Frits; Schinke, Carolina; Thanendrarajan, Sharmilan; Barlogie, Bart; Davies, Faith E; Morgan, Gareth J; Yaccoby, Shmuel

British journal of haematology. 2019 Feb; 184(4):578-593

See All Publications (451)

Read Story